BRIDGEBIO PHARMA INC: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in BRIDGEBIO PHARMA INC. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
4
13F filers
Aggregate Value
$167.9M
Across holders
Last Price
—
EOD close
Sector
—
GICS
Quarterly fund activity2 increased0 reduced1 exited
Full exits: SHAW D E & CO INC
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| Sculptor Capital LP CIK 0001054587 | Hedge Fund | 70.00M | $117.9M | 70.2% | 1.0% | Added | +$50.5M | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 29.00M | $48.8M | 29.1% | 0.0% | Added | — | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 500K | $842K | 0.5% | 0.0% | Unchanged | +$0 | Q2 2026 |
| Man Group plc CIK 0001637460 | Hedge Fund | 225K | $379K | 0.2% | 0.0% | Unchanged | +$0 | Q2 2026 |
Added
Hedge Fund
$117.9M· 70.2% of total· 1.0% port· 70.00M sh· +$50.5M QoQ· Q2 2026
Added
Hedge Fund
$48.8M· 29.1% of total· 0.0% port· 29.00M sh· — QoQ· Q2 2026
Unchanged
Hedge Fund
$842K· 0.5% of total· 0.0% port· 500K sh· +$0 QoQ· Q2 2026
Unchanged
Hedge Fund
$379K· 0.2% of total· 0.0% port· 225K sh· +$0 QoQ· Q2 2026